Abstract

Antibodies against the Membrane-Proximal External Region (MPER) of the Env gp41 subunit neutralize HIV-1 with exceptional breadth and potency. Due to the lack of knowledge on the MPER native structure and accessibility, different and exclusive models have been proposed for the molecular mechanism of MPER recognition by broadly neutralizing antibodies. Here, accessibility of antibodies to the native Env MPER on single virions has been addressed through STED microscopy. STED imaging of fluorescently labeled Fabs reveals a common pattern of native Env recognition for HIV-1 antibodies targeting MPER or the surface subunit gp120. In the case of anti-MPER antibodies, the process evolves with extra contribution of interactions with the viral lipid membrane to binding specificity. Our data provide biophysical insights into the recognition of the potent and broadly neutralizing MPER epitope on HIV virions, and as such is of importance for the design of therapeutic interventions.

The Membrane-Proximal External Region (MPER) of the HIV Env gp41 subunit is a target for broadly neutralizing antibodies. Here, the authors apply super-resolution stimulated emission depletion (STED) microscopy on single virions and provide insights into how the MPER epitope is recognized.

Details

Title
Molecular recognition of the native HIV-1 MPER revealed by STED microscopy of single virions
Author
Carravilla Pablo 1   VIAFID ORCID Logo  ; Chojnacki Jakub 2   VIAFID ORCID Logo  ; Rujas Edurne 1 ; Insausti, Sara 1 ; Largo Eneko 1 ; Waithe Dominic 2   VIAFID ORCID Logo  ; Apellaniz Beatriz 1 ; Sicard Taylor 3 ; Jean-Philippe, Julien 4   VIAFID ORCID Logo  ; Eggeling, Christian 5 ; Nieva, José L 1 

 University of the Basque Country (UPV/EHU), Biofisika Institute (CSIC, UPV/EHU) and Department of Biochemistry and Molecular Biology, Bilbao, Spain (GRID:grid.11480.3c) (ISNI:0000000121671098) 
 University of Oxford, MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948) 
 The Hospital for Sick Children Research Institute, Program in Molecular Medicine, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646) ; University of Toronto, Department of Biochemistry, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
 The Hospital for Sick Children Research Institute, Program in Molecular Medicine, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646) ; University of Toronto, Department of Biochemistry, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) ; University of Toronto, Department of Immunology, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
 University of Oxford, MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948) ; Institute of Applied Optics Friedrich-Schiller-University Jena, Jena, Germany (GRID:grid.9613.d) (ISNI:0000 0001 1939 2794) ; Leibniz Institute of Photonic Technology e.V., Jena, Germany (GRID:grid.418907.3) (ISNI:0000 0004 0563 7158) 
Publication year
2019
Publication date
Jan 2019
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2165096528
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.